Catalyst Wire Dossier Catalyst Wire Dossier

Dexmedetomidine Transdermal System

dexmedetomidine · Teikoku Pharma USA, Inc.
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Dexmedetomidine Transdermal System, covering 2020-07-23 to 2025-12-24. Get the full timeline:

Most recent: Clinical Trial Update: Evaluation of the Dexmedetomidine Transdermal Systems for Postoperative Analgesia Following Abdominoplasty [Phase 2]

See pricing